2-氟-4-甲基苯甲酸乙酯 | 500579-61-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氟-4-甲基苯甲酸乙酯
• 英文名称: ethyl 2-fluoro-4-methylbenzoate
• CAS: 500579-61-3
• 化学式: C₁₀H₁₁FO₂
• 分子量: 182.195
• InChiKey: ZWWVHEVIVRTABT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  2-氟-4-甲基苯甲酸乙酯 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以10.0 g的产率得到ethyl 4-(bromomethyl)-2-fluorobenzoate
  参考文献：
  名称：

  EP3858828

  摘要：

  公开号：
• 作为产物：
  描述：

  2-氟-4-甲基苯甲酸 在 硫酸 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以15.0 g的产率得到2-氟-4-甲基苯甲酸乙酯
  参考文献：
  名称：

  EP3858828

  摘要：

  公开号：

文献信息

• [EN] BIARYLOXY DERIVATIVES AS TTX-S BLOCKERS<br/>[FR] DÉRIVÉS DE BIARYLOXY UTILISÉS EN TANT QUE BLOQUEURS DE TTX-S
  申请人：RAQUALIA PHARMA INC

  公开号：WO2019045035A1

  公开（公告）日：2019-03-07

  The present invention relates to biaryloxy derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channel is involved.　The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及具有阻断活性的双芳氧基衍生物，可作为TTX-S通道的阻断活性，并且可用于治疗或预防涉及电压门控钠通道的紊乱和疾病。该发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及电压门控钠通道的疾病中使用这些化合物和组合物。
• Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
  申请人：——

  公开号：US20020123632A1

  公开（公告）日：2002-09-05

  Substituted anthranilic acids of the formula I 1 their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker.

  公式I1的取代蒽酸及其作为药物或诊断工具的用途，以及包含它们的药物，以及含有钠/氢交换（NHE）阻滞剂的药物组合制剂。
• Pyrrolidine derivative or salt thereof
  申请人：Hachiya Shunichiro

  公开号：US20090062366A1

  公开（公告）日：2009-03-05

  [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).

  [问题] 提供一种可用于治疗钙敏感受体（CaSR）相关疾病，特别是甲状旁腺功能亢进症的化合物。 [解决方法] 发现了一种新型吡咯烷衍生物，其特征在于具有氨甲基基团，该基团被芳基烷基或类似物取代，或其盐，具有出色的CaSR激动调节活性，并且具有出色的选择性与CYP2D6抑制活性，可能导致药物相互作用。基于以上发现，这些新型吡咯烷衍生物可用作治疗CaSR相关疾病（甲状旁腺功能亢进症，肾性骨营养不良，高钙血症等）的治疗剂。
• ANTIDIABETIC TRICYCLIC COMPOUNDS
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20160207887A1

  公开（公告）日：2016-07-21

  Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslip idemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

  结构式（I）的新化合物及其药学上可接受的盐是G蛋白偶联受体40（GPR40）的激动剂，可用于治疗、预防和抑制由G蛋白偶联受体40介导的疾病。本发明的化合物可用于治疗2型糖尿病，以及与该疾病常见相关的情况，包括肥胖和脂质紊乱，如混合型或糖尿病性脂质异常、高脂血症、高胆固醇血症和高甘油三酯血症。
• RETINOID COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF AND APPLICATION THEREOF
  申请人：Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

  公开号：EP3428155A1

  公开（公告）日：2019-01-16

  Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.

  本发明公开了一种维甲酸化合物、其制备方法、中间体及其应用。本发明的维甲酸化合物 I 具有良好的肿瘤生长抑制率。